Customizing the degradation and load-bearing profile of 3D polycaprolactone-tricalcium phosphate scaffolds under enzymatic and hydrolytic conditions

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 87, Issue 2, 2008, Pages 562-569

  Yeo, Alvin ^a,b   Sju, Ervi ^b   Rai, Bina ^c   Teoh, Swee Hin ^b  

^a Singapore Health Services   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Osteopore International Private Limited   (Singapore)

Author keywords

Degradation; Mechanical properties; Polycaprolactone; Scaffold; Surface roughness

Indexed keywords

BIOLOGICAL MATERIALS; BIOMATERIALS; BONE; COMPRESSIVE STRENGTH; DEGRADATION; FRICTION; ICE; MECHANICAL PROPERTIES; MECHANICAL TESTING; SODIUM; STRENGTH OF MATERIALS; SURFACE PROPERTIES; SURFACE ROUGHNESS; TRANSMISSION CONTROL PROTOCOL;

APPLICATIONS.; DEGRADATION RATES; DEGREE OF DEGRADATIONS; GREAT-ER; HYDROLYTIC CONDITIONS; LIPASE SOLUTIONS; PRETREATMENT; SODIUM HYDROXIDES; TRICALCIUM PHOSPHATES; WEIGHT LOSSES;

SCAFFOLDS;

BIOMATERIAL; CALCIUM PHOSPHATE; POLYCAPROLACTONE; SODIUM HYDROXIDE; TRIACYLGLYCEROL LIPASE;

ARTICLE; BONE REGENERATION; COMPRESSIVE STRENGTH; DEGRADATION; DENTISTRY; POROSITY;

CALCIUM PHOSPHATES; HYDROLYSIS; LIPASE; MICROSCOPY, ELECTRON, SCANNING; MODELS, MOLECULAR; MOLECULAR WEIGHT; POLYESTERS; STRESS, MECHANICAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 55049126465     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31145     Document Type: Article

References (33)

1. Buser D, Dula K, Hirt HP, Schenk RK. Lateral ridge augmentation using autografts and barrier membranes: a clinical study with 40 partially edentulous patients. J Oral Maxillofac Surg 1996;54:420-432.
2. Buser D, Dula K, Hess D, Hirt HP, Belser UC. Localized ridge augmentation with autografts and barrier membranes. Periodontol 2000 1999;19:151-163.
3. von Arx T, Buser D. Horizontal ridge augmentation using autogenous block grafts and the guided bone regeneration technique with collagen membranes: a clinical study with 42 patients. Clin Oral Implants Res 2006;17:359-366.
4. McAllister BS, Haghighat K. Bone augmentation techniques. J Periodontol 2007;78:377-396.
5. Lei Y, Rai B, Ho KH, Teoh S H. In vitro degradation of novel bioactive polycaprolactone-20% tricalcium phosphate composite scaffolds for bone engineering. Mater Sci Eng C 2007;27:293-298.
6. Rai B, Teoh SH, Ho KH, Hutmacher DW, Cao T, Chen F, Yacob K. The effect of rhBMP-2 on canine osteoblasts seeded onto 3D bioactive polycaprolactone scaffolds. Biomaterials 2004;25:5499-5506.
7. Rai B, Teoh SH, Ho KH. An in vitro evaluation of PCL-TCP composites as delivery systems for platelet-rich plasma. J Control Release 2005;107:330-342.
8. Rai B, Teoh SH, Hutmacher DW, Cao T, Ho KH. Novel PC. L-Based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials 2005;26:3739-3748.
9. Rai B, Oest ME, Dupont KM, Ho KH, Teoh SH, Guldberg RE. Combination of platelet-rich plasma with polycaprolactone-tricalcium phosphate scaffolds for segmental bone defect repair. J Biomed Mater Res A 2007;81:888-899.
10. Rai B, Ho KH, Lei Y, Si-Hoe KM, Jeremy Teo CM, Yacob KB, Chen F, Nq FC, Teoh SH. Polycaprolactore-20% tricalcium phosphate scaffolds in combination with platelet-rich plasma for the treatment of critical-sized defects of the mandible: a pilot study. J Oral Maxillofac Surg 2007;65:2195-2205.
11. Yeo A, Rai B, Sju E, Cheong JJ, Teoh SH. The degradation profile of novel, bioresorbable PCL-TCP scaffolds: An in vitro and in vivo study. J Biomed Mater Res A 2008;84:208-218.
12. Kay S, Thapa A, Haberstroh KM, Webster TJ. Nanostructured polymer: Nanophase ceramic composites enhance osteoblast and chondrocyte adhesion. Tissue Eng 2002;8:753-761.
13. Liu H, Slamovich EB, Webster TJ. Increased osteoblast functions among nanophase titania/poly(lactide-co-glycolide) composites of the highest nanometer surface roughness. J Biomed Mater Res A 2006;78:798-807.
14. Coombes AGA, Rizzi SC, Williamson M, Barralet JE, Downes S, Wallace WA. Precipitation casting of polycaprolactone for applications in tissue engineering and drug delivery. Biomaterials 2004;25:315-325.
15. Gan Z, Fung JT, Jing X, Wu C, Kuliche WK. A novel laser light-scattering study of enzymatic biodegradation of poly (ε-caprolactone) nanoparticles. Polymer 1999;40:1961-1967.
16. Pitt CG, Chasalow FI, Hibionada YA, Klimas DM, Schindler A. Aliphatic polyesters. I. The degradation of poly (ε-caprolactone) in vivo. J Appl Polym Sci 1981;26:3779.
17. Sun H, Mei L, Song C, Cui X, Wang P. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials 2006;27:1735-1740.
18. Htay AS, Teoh SH, Hutmacher DW. Development of perforated microthin poly(epsilon-caprolactone) films as matrices for membrane tissue engineering. J Biomater Sci Polym Ed 2004;15:683-700.
19. Lu CH, Lin WJ. Permeation of protein from porous poly (epsilon-caprolactone) films. J Biomed Mater Res 2002;63:220-225.
20. Lam CXF, Teoh SH, Hutmacher DW. Comparison of the degradation of polycaprolactone and polycaprolactone-(β-tricalcium phosphate) scaffolds in alkaline medium. Polym Int 2007;56:718-728.
21. Schantz JT, Hutmacher DW, Ng KW, Khor HL, Lim MT, Teoh SH. Evaluation of a tissue-engineered membrane-cell construct for guided bone regeneration. Int J Oral Maxillofac Implants 2002;17:161-174.
22. Burkersroda FV, Schedl L, Gopferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials 2002;23:4221-4231.
23. Park GE, Pattison MA, Park K, Webster TJ. Accelerated chondrocyte functions on NaOH-treated PLGA scaffolds. Biomaterials 2005;26:3075-3082.
24. Li S, Garreau H, Pauvert B, McGrath J, Toniolo A, Vert M. Enzymatic degradation of block copolymers prepared from epsilon-caprolactone and poly(ethylene glycol). Biomacromolecules 2002;3:525-530.
25. Chawla JS, Amiji MM. Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002;249:127-138.
26. Marletta G, Ciapetti G, Satriano C, Perut F, Salerno M, Baldini N. Improved osteogenic differentiation of human marrow stromal cells cultured on ion-induced chemically structured poly-epsilon-caprolactone. Biomaterials 2007;28:1132-1140.
27. Kawahara H, Soeda Y, Niwa K, Takahashi M, Kawahara D, Araki N. In vitro study on bone formation and surface topography from the standpoint of biomechanics. J Mater Sci Mater Med 2004;15:1297-1307.
28. Wan Y, Yu A, Wu H, Wang Z, Wen D. Porous-conductive chitosan scaffolds for tissue engineering II. In vitro and in vivo degradation. J Mater Sci Mater Med 2005;16:1017-1028.
29. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005;26:5474-5491.
30. Jones AC, Arns CH, Sheppard AP, Hutmacher DW, Milthorpe BK, Knackstedt MA. Assessment of bone ingrowth into porous biomaterials using MICRO-CT. Biomaterials 2007;28:2491-2504.
31. Srivastava RK, Albertsson AC. Porous scaffolds from high molecular weight polyesters synthesized via enzyme-catalyzed ring-opening polymerization. Biomacromolecules 2006;7:2531-2538.
32. Okamoto M, Dohi Y, Ohgushi H, Shimaoka H, Ikeuchi M, Matsushima A, Yonemasu K, Hosoi H. Influence of the porosity of hydroxyapatite ceramics on in vitro and in vivo bone formation by cultured rat bone marrow stromal cells. J Mater Sci Mater Med 2006;17:327-336.
33. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006;27:3413-3431.